send to a friend by email
2018-04-30
According to the financial statements of Jerusalem Pharmaceuticals JPH for the quarter of 2018, Net profit after tax of the period reached 1,188,800 USD Compared with Net profit after tax 1,605,998 USD for 2017, a net decrease in profit of 25.98%.Total assets of the company reached 62,652,758 USD compared with total assets of 61,625,755 USD at the end of year 2017, a net increase of 1.67%.Total liabilities of the company reached 12,109,427 USD compared with total liabilities of 12,237,751 USD at the end of year 2017, a net decrease of 1.04%. Net ownership equity of the company reached 50,543,331 USD (Including Non-Controlling Interests of 842,333 USD) compared with total owner equity of 49,388,004 USD (Including Non-Controlling Interests of 851,077 USD) at the end of year 2017, a net increase of 2.34%.
|
|